Tuberculosis associated with therapy against tumor necrosis factor α-Reference-Cited by-同舟云学术

Tuberculosis associated with therapy against tumor necrosis factor α

Published:2005 Issue:10 Volume:52 Page:2968-2974
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Winthrop Kevin L.,Siegel Jeffrey N.,Jereb John,Taylor Zachary,Iademarco Michael F.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference33 articles.

1. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

2. US Food and Drug Administration, Arthritis Drugs Advisory Committee. Update on the TNF-α blocking agents. URL: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3930b1.htm.

3. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

4. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary tuberculosis infection and CMV reactivation following daratumumab treatment in a patient with relapsed plasmablastic lymphoma;Blood Science;2022-08-26

2. Disseminated Tuberculosis in a Psoriasis Patient under Adalimumab Treatment despite the Chemoprophylaxis of Latent Tuberculosis: A Case Report;Annals of Dermatology;2021

3. Marine-Derived Biologically Active Compounds for the Potential Treatment of Rheumatoid Arthritis;Marine Drugs;2020-12-29

4. Mycobacterial Infections Potentiated by Biologics;Infectious Disease Clinics of North America;2020-06

5. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations;Journal for ImmunoTherapy of Cancer;2019-09-04